RISE: Reducing Cancer and HIV Stigma Through Empowerment

{ "RISE: Reducing Cancer and HIV Stigma Through Empowerment", "This study, called RISE, is looking at ways to reduce the stigma (negative feelings or beliefs) associated with having both cervical cancer and HIV. It's testing different behavioral interventions, including watching neutral videos, watching storytelling videos, talking or writing about experiences (self-disclosure), or a combination of these. The study involves women with cervical cancer and HIV, as well as healthcare workers. Researchers want to see if these interventions can improve quality of life for patients and reduce stigma and increase compassion among healthcare workers. The study is taking place in Zambia and aims to enroll 440 participants.", "design": "This is an interventional study with a planned enrollment of 440 participants. It uses a randomized design, meaning participants are assigned by chance to different intervention groups.", "commitments": "Participants will watch videos and/or talk/write about their experiences. Quality of life will be measured at baseline, immediately after the intervention, and at 1, 3, 6, and 12 months.", "compensation": "Not stated in the trial record.", "follow_up": "Participants will be followed for 12 months after the intervention to assess quality of life.", }

Study design
Not specified.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07728370

RISE: Reducing Cancer and HIV Stigma Through Empowerment

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
M.D. Anderson Cancer Center
~440 participants
Updated 2026-07-27 on ClinicalTrials.gov
What's tested:Neutral VideoStorytellingSelf disclosureCombinationVideoWaitlist

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Quality of Life (Cancer)
Measured over Baseline, immediately after the intervention, and 1-, 3-, 6-, and 12- month follow up
+1 more outcome measured
HIV
Cervical Cancer Stigma
1 sites across 1 states
Texas1
  • Qian Lu, MD, PHD · PRINCIPAL_INVESTIGATOR · UT MD Anderson

Opens a ready-to-send draft in your own email app — review before sending.

  • Quality of Life (Cancer)Baseline, immediately after the intervention, and 1-, 3-, 6-, and 12- month follow up

    Quality of life (cancer) will be assessed using the Functional Assessment of Cancer Therapy - General (FACT-G). The FACT-G contains 27 items that assess perceived quality of life of patients living with cancer over the past week.

  • Patient-level: Quality of Life (HIV)Baseline, immediately after the intervention, and 1-, 3-, 6-, and 12- month follow up

    Quality of life (HIV) will be assessed using a shortened version of the Patient-Reported Outcomes Quality of Life-HIV (PROQOL-HIV). The shortened PROQOL-HIV scale has four factors: physical health and symptoms; health concerns and mental distress, social and intimate relationships, and treatment impact.